International Journal of Pharmaceutical Investigation logo
Review

Overview on Evolving Variants of Novel Coronavirus and Control Measures in India

1, 1, 1★★ Corresponding author

  1. 1Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, INDIA.

CORRESPONDENCE

Sumitha R

Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, INDIA.

sumithamadhu79@gmail.com

Received: 04-02-2023; Revised: 17-03-2023; Accepted: 30-03-2023.

Volume 13, Issue 3 · pp. 373-380 · 2023 · DOI: 10.5530/ijpi.13.3.048

ABSTRACT

The new coronavirus has spread to more than 200 nations since it first appeared in China in December 2019. Worldwide, there have been more than 58.3 billion confirmed cases of the coronavirus and more than 64.2 lakh fatalities as of August 2022. In India, more than 4.41 billion confirmed cases and more than 5.27 lakh fatalities have occurred. The outbreak of coronavirus 2019 (COVID-19) was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In India, the outbreak led to the imposition of a nationwide lockdown, which resulted in a sharp decrease in the number of new confirmed cases. However, in recent months, there has been an increase in new COVID-19 cases in India, with a number of new variants of the virus being detected. The variants found in India are Alpha, Beta, Gamma, Delta, Kappa, Omicron, and B.1.618 (Triple mutant). Although the symptoms of the virus closely align with the common cold, during severe infection, one may experience loss of smell and taste sensation and long-term infection can lead to post-COVID complications. The Indian government has implemented a number of treatment strategies in an effort to control the spread of the disease and reduce the number of fatalities. As the pandemic situation continues to evolve, there is an urgent need to understand the epidemiology of the disease and the characteristics of the virus. In this review, we provide a summary of our current understanding of the novel coronavirus, the mutant novel strains that are prevalent in India, the epidemiology of COVID-19, and the control measures that have been put in place in India and their effectiveness in halting the disease's spread.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    P, P., G, J. M., & R, S. (2023). Overview on Evolving Variants of Novel Coronavirus and Control Measures in India. International Journal of Pharmaceutical Investigation, 13(3), 373-380. https://doi.org/10.5530/ijpi.13.3.048

    Copyright and licence

    © 2023 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0